V

VYNE Therapeutics
D

VYNE

0.59680
USD
0.01
(1.10%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
19,865,337
أصول ذات صلة المقالات

العنوان: VYNE Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.